Pharmaceutical industry payments to Australian patient groups: January 2013 to December 2022

Abstract

This dataset includes data from transparency reports from the pharmaceutical industry from 2013-2022 of payments to patient groups. Since 2013, companies which are members of Medicines Australia (the peak body for the prescription pharmaceutical industry in Australia) have been required by the Medicines Australia Code of Conduct to disclose any financial and significant non-financial support provided to patient groups. These reports are published on the Medicines Australia website for a period of three years and include information on the recipient patient group, a brief description of the support provided, and the monetary value of the sponsorship.